Healthcare Industry News Weekly Wrap-Up: September 3, 2022
// Biotech and Pharma Therapeutics Eisai and Biogen’s phase 3 Alzheimer’s win puts amyloid back in the driver’s seat, for now September 28, 2022 / Biogen / Eisai / Alzheimer’s / Iecanemab The two pharma partners found that lecanemab slowed...